Dracen Pharmaceuticals
Initial Transaction Details
Transaction Date
January 2018
Purpose of Financing
Venture
Stage of Company
Mid Stage
Structure of Financing
Equity
Dracen Pharmaceuticals, Inc. is a privately held biotech company developing proprietary anti-cancer drugs that target immuno-metabolism.
Website